Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cancers|October 1, 2014
Monoclonal Antibodies Specific for STAT3β Reveal Its Contribution to Constitutive STAT3 Phosphorylation in Breast CancerUddalak Bharadwaj, Moses M Kasembeli, T Kris Eckols, et al.
Blood|November 2, 2016
Protein stabilization improves STAT3 function in autosomal dominant hyper-IgE syndromeClaire E Bocchini, Karen Nahmod, Panagiotis Katsonis, et al.
American Journal of Physiology. Renal Physiology|June 2, 2020
Pharmacokinetics and pharmacodynamics of TTI-101, a STAT3 inhibitor that blocks muscle proteolysis in rats with chronic kidney diseaseLiping Zhang, Ying Wang, Yanlan Dong, et al.
Biochemical Pharmacology|July 18, 2021
TTI-101: A competitive inhibitor of STAT3 that spares oxidative phosphorylation and reverses mechanical allodynia in mouse models of neuropathic painMoses M Kasembeli, Pooja Singhmar, Jiacheng Ma, et al.
Oncotarget|March 31, 2016
Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinomaUddalak Bharadwaj, T Kris Eckols, Xuejun Xu, et al.
Oncotarget|March 23, 2019
Correction: Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinomaUddalak Bharadwaj, T Kris Eckols, Xuejun Xu, et al.
Angewandte Chemie (International Ed. in English)|October 20, 2015
Rhodium(II) Proximity-Labeling Identifies a Novel Target Site on STAT3 for Inhibitors with Potent Anti-Leukemia ActivityMatthew B Minus, Wei Liu, Farrukh Vohidov, et al.
Pharmacological Research|May 1, 2021
Novel STAT3 small-molecule inhibitors identified by structure-based virtual ligand screening incorporating SH2 domain flexibilityRen Kong, Uddalak Bharadwaj, T Kris Eckols, et al.
Organic & Biomolecular Chemistry|April 15, 2020
Targeting STAT3 anti-apoptosis pathways with organic and hybrid organic-inorganic inhibitorsMatthew B Minus, Haopei Wang, Jaime O Munoz, et al.
Frontiers in Immunology|May 13, 2025
Selective inhibition of canonical STAT3 signaling suppresses K-ras mutant lung tumorigenesis and reinvigorates anti-tumor immunityMichael J Clowers, Zahraa Rahal, Sung-Nam Cho, et al.
Pageof 2